Volume 4, Issue 4, Pages (October 2003)

Slides:



Advertisements
Similar presentations
Lessons from Hereditary Colorectal Cancer
Advertisements

Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription Chia-Hsin.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Untangling P-Bodies: Dissecting the Complex Web of Interactions that Enable Tiered Control of Gene Expression  Christopher J. Kershaw, Mark P. Ashe  Molecular.
Charles Swanton, Julian Downward  Cancer Cell 
Volume 107, Issue 7, Pages (December 2001)
UneCLIPsing HuR Nuclear Function
Volume 100, Issue 1, Pages (January 2000)
IRS-1: Auditing the effectiveness of mTOR inhibitors
Warren S. Pear, M. Celeste Simon  Cancer Cell 
Plant Physiology: Out in the Midday Sun, Plants Keep Their Cool
Cell signaling and cancer
The linchpin? Pin1 meets p73
Taking T Cell Priming Down a Notch: Signaling through Notch Receptors Enhances T Cell Sensitivity to Antigen  Timothy J. Thauland, Manish J. Butte  Immunity 
mRNA Trafficking and Local Protein Synthesis at the Synapse
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
A Pause to Splice Molecular Cell
Integrating mRNA Processing with Transcription
The Autistic Neuron: Troubled Translation?
Identification of TOR Signaling Complexes
A New Link in the Chain from Amino Acids to mTORC1 Activation
Apoptosis-targeted therapies for cancer
P Bodies and the Control of mRNA Translation and Degradation
Shrikant Anant, Courtney W. Houchen  Gastroenterology 
RNA-Seeded Functional Amyloids Balance Growth and Survival
Volume 3, Issue 4, Pages (April 2003)
Vascular Endothelial Growth Factor (VEGF) Pathway
PAF Makes It EZ(H2) for β-Catenin Transactivation
Eukaryotic Transcription Activation: Right on Target
Pattern Recognition Receptors
Characterizing the Killer Colorectal Carcinomas
IRS-1: Auditing the effectiveness of mTOR inhibitors
Stop that Noise and Turn Up the Antisense Transcription
Multiplying Messages LRRK beneath Parkinson Disease
Ars2 and the Cap-Binding Complex Team up for Silencing
Untangling P-Bodies: Dissecting the Complex Web of Interactions that Enable Tiered Control of Gene Expression  Christopher J. Kershaw, Mark P. Ashe  Molecular.
Volume 12, Issue 4, Pages (October 2003)
Valerie Blanc, Nicholas O. Davidson  Gastroenterology 
Volume 150, Issue 5, Pages (May 2016)
A new mouse model of pancreatic cancer: PTEN gets its Akt together
Nuclear Decay Factors Crack Up mRNA
Proteins Kinases: Chromatin-Associated Enzymes?
Modifications on Translation Initiation
Translational Control: Awakening dormant mRNAs
Division of Labor: Minor Splicing in the Cytoplasm
Proteins in Plant Brassinosteroid Signaling
Apoptosis-targeted therapies for cancer
microRNAs: A Safeguard against Turmoil?
Regulatory Nascent Peptides in the Ribosomal Tunnel
mTOR Regulation by JNK: Rescuing the Starving Intestinal Cancer Cell?
Alex Kentsis, A. Thomas Look  Cell Stem Cell 
Simon Ekman, MD, PhD, Murry W. Wynes, PhD, Fred R. Hirsch, MD, PhD 
Smoothing Out Drug Resistance
Genetic Changes in Squamous Cell Lung Cancer: A Review
Increased understanding leads to increased complexity: Molecular mechanisms of pulmonary arterial hypertension  Victor A. Ferraris, MD, PhD  The Journal.
Regina M. Vidaver, PhD, Beth S. Schachter, PhD 
Volume 35, Issue 6, Pages (December 2011)
Splicing and Dicing MYC-Mediated Synthetic Lethality
Tailor Made Protein Synthesis for HSCs
Mutant BRAF Melanomas—Dependence and Resistance
Volume 22, Issue 4, Pages (April 2018)
Volume 163, Issue 2, (October 2015)
Volume 108, Issue 4, Pages (February 2002)
There's a Time and a Place for MYCN
TFII-IΔ and TFII-Iβ: Unequal Brothers Fostering Cellular Proliferation
Ivan Topisirovic, Nahum Sonenberg  Cell 
Radiation does not alter AKT and MTOR gene expression.
Skp2, the FoxO1 hunter Cancer Cell
Volume 3, Issue 4, Pages (April 2003)
Presentation transcript:

Volume 4, Issue 4, Pages 244-245 (October 2003) Signal transduction  George C Prendergast  Cancer Cell  Volume 4, Issue 4, Pages 244-245 (October 2003) DOI: 10.1016/S1535-6108(03)00247-2

Figure 1 Ras/Akt signaling to translation Ras signaling through ERK and Akt signaling through mTOR lead to the control of translational effects at the level of cap-dependent recruitment of mRNAs to polysomes and perhaps other cap-independent effects. Patterns of polysomal mRNA recruitment are altered rapidly, before the complexity of total cellular RNA is altered significantly by changes in transcription patterns. Holland and colleagues observed that ∼20% of the mRNAs influenced by Ras/Akt at the level of polysomal recruitment encoded transcription factors (Rajasekhar et al., 2003), in support of the idea that translational effects may precede transcriptional effects of Ras/Akt signaling. Cancer Cell 2003 4, 244-245DOI: (10.1016/S1535-6108(03)00247-2)